 |
市場調査レポート
商品コード
1292329
米国の造影剤と放射性医薬品市場：Medtech 360Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | United States |
||||||
価格
| 米国の造影剤と放射性医薬品市場：Medtech 360 |
|
出版日: 2023年06月13日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日
|
- 全表示
- 概要
- 目次
概要
米国の造影剤と放射性医薬品の市場規模は、2020年のCOVID-19パンデミックによって大きな影響を受けましたが、2021年と2022年にはすでに大幅な回復を見せています。しかし、サプライチェーンの混乱、特に上海でのロックダウンによる悪影響は続いています。同市場は、CEUSやPET検査における画像診断薬の使用拡大が成長の促進要因となるとみられています。
当レポートでは、米国の造影剤と放射性医薬品市場について調査し、市場の概要とともに、2019年～2032年のセグメント別の市場動向と予測データ、競合動向などを提供しています。
目次
米国
概要
エグゼクティブサマリー
主要なレポートの更新
造影剤と放射性医薬品市場
- 市場のハイライト
- 市場の定義
- 市場予測データ
- 市場シェア
- 競合考察
- Cardinal Health
- GE Healthcare
- Bracco Group
- Lantheus Holdings
- Bayer Healthcare
- その他の主要な競合企業
- すべての競合企業に影響を与える要因
- 市場の発展
放射性医薬品市場
- 市場のハイライト
- 市場の定義
- 市場予測データ
- 市場シェア
- 競合要因と戦略
- 競合考察
- 米国の放射性医薬品市場の競合考察
- すべての競合企業に影響を与える要因
CTおよびX線造影剤市場
- 市場のハイライト
- 市場の定義
- 市場予測データ
- 市場シェア
- 競合考察
- 米国のCTおよびX線造影剤市場の競合考察
MRI造影剤市場
- 市場のハイライト
- 市場の定義
- 市場予測データ
- 市場シェア
- 競合考察
- 米国のMRI造影剤市場の競合考察
- すべての競合企業に影響を与える要因
超音波造影剤市場
- 市場のハイライト
- 市場の定義
- 市場予測データ
- 市場シェア
- 競合考察
- 米国の超音波造影剤市場の競合考察
付録
調査手法
目次
Product Code: 47041152
The US contrast agents and radiopharmaceutical market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022; however, it continues to be negatively impacted by disrupted supply chains, particularly due to lockdowns in Shanghai. Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities. Additionally, the shift toward value-based care will act as a barrier for certain procedures, favoring instead those that offer the highest levels of accuracy and clarity in visualization.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for contrast agents and radiopharmaceuticals in the US from 2019 through 2032.
The COVID-19 pandemic negatively affected the contrast agent and radiopharmaceutical market.
- To what extent has the COVID-19 pandemic impacted the contrast agent and radiopharmaceutical market in the US?
- How has the impact of the COVID-19 pandemic varied between segments?
- How quickly are procedure volumes expected to completely recover?
- How has COVID-19-related use of contrast-enhanced CT and ultrasound impacted procedure volumes?
The FDA recently expanded approval for the use of CEUS in radiology procedures.
- What types of procedures does this approval extend to? Which additional procedures could be approved in the future?
- Which contrast agents received FDA approval?
- How will competitors that do not have FDA approval react?
Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.
- How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
- What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
- Will other imaging modalities cannibalize contrast-enhanced MRI procedures?
- Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?
The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the shortening supply of Mo-99 and Tc-99.
- What novel technology is showing promise that could help with global supply of Tc-99?
- How will the transition from HEU to LEU reactors affect ASPs in the US market?
- How will the US deal with the shortage of Mo-99?
The contrast agents segment will see a shakeup eventually due to the patent expirations and launch of generic products.
- What effects will this have on competition and ASP in the contrast agents space?
- How will major players secure its market share in the face of potential new competition?
Table of Contents
United States
Abstract
Executive Summary
- COVID-19 Updates
- Market Highlights
- Competitive Highlights
- Market Developments
- Procedures and Products Covered
Key Report Updates
Contrast Agent and Radiopharmaceutical Market
- Market Highlights
- Key Content Updates
- Market Definitions
- Market Forecast Data
- Market Shares
- Competitive Insights
- Cardinal Health
- GE Healthcare
- Bracco Group
- Lantheus Holdings
- Bayer Healthcare
- Other Key Competitors
- Factors Affecting All Competitors
- Market Developments
Radiopharmaceutical Market
- Market Highlights
- Key Content Updates
- Market Definitions
- Market Forecast Data
- Market Shares
- Competitive Factors and Strategies
- Competitive Insights
- US Radiopharmaceutical Market Competitive Insights
- Factors Affecting All Competitors
CT and X-Ray Contrast Agent Market
- Market Highlights
- Key Content Updates
- Market Definitions
- Market Forecast Data
- Market Shares
- Competitive Insights
- US CT and X-Ray Contrast Agent Market Competitive Insights
MRI Contrast Agent Market
- Market Highlights
- Key Content Updates
- Market Definitions
- Market Forecast Data
- Market Shares
- Competitive Insights
- US MRI Contrast Agent Market Competitive Insights
- Factors Affecting All Competitors
Ultrasound Contrast Agent Market
- Market Highlights
- Key Content Updates
- Market Definitions
- Market Forecast Data
- Market Shares
- Competitive Insights
- US Ultrasound Contrast Agent Market Competitive Insights
Appendix
- Abbreviations
- Bibliography
Methodology
- Core Country Coverage Methodology
- Research Methodology
- Marketrack Methodology
- PriceTrack Methodology
- Forecast Methodology
- Supplemental Country Coverage Methodology
- Base-Year Ratio Analysis
- Market Forecasting
Tables and Figures
- Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2032
- Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2022 and 2032
- Competitive Insights
- Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2022
- Companies Mentioned
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
- Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
- Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
- US Contrast Agent and Radiopharmaceutical Market Drivers
- US Contrast Agent and Radiopharmaceutical Market Limiters
- Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2032
- Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2032
- Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2032
- Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2022
- Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2022
- Cardinal Health Competitive Insights
- GE Healthcare Competitive Insights
- Bracco Group Competitive Insights
- Lantheus Holdings Competitive Insights
- Bayer Healthcare Competitive Insights
- Competitive Insights for Other Key Competitors
- Factors Affecting All Competitors
- Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
- Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
- US Radiopharmaceutical Market Drivers
- US Radiopharmaceutical Market Limiters
- Radiopharmaceutical Market, by Product Type, US (USD), 2019-2032
- Radiopharmaceutical Market, by Product Type, US (USD), 2019-2032
- Radiopharmaceutical Market Growth, by Product Type, US, 2020-2032
- Nuclear Medicine System Installed Base, by Product Type, US, 2019-2032
- Radiopharmaceutical Revenue Market Shares, US, 2022
- Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2022
- Competitive Factors and Strategies, US
- US Radiopharmaceutical Market Competitive Insights
- Factors Affecting All Competitors
- US CT and X-Ray Contrast Agent Market Drivers
- US CT and X-Ray Contrast Agent Market Limiters
- CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2032
- CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2032
- CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2032
- CT and X-Ray System Installed Base, by Product Type, US, 2019-2032
- CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2032
- CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2032
- X-Ray, Contrast Agent Market, by Procedure Type, US (USD), 2019-2032
- CT and X-Ray Contrast Agent Revenue Market Shares, US, 2022
- CT and X-Ray Contrast Agent Revenue Market Shares, US, 2022
- US CT and X-Ray Contrast Agent Market Competitive Insights
- US MRI Contrast Agent Market Drivers
- US MRI Contrast Agent Market Limiters
- MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2032
- MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2032
- MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2032
- MRI System Installed Base, US, 2019-2032
- MRI Contrast Agent Revenue Market Shares, US, 2022
- MRI Contrast Agent Revenue Market Shares, US, 2022
- US MRI Contrast Agent Market Competitive Insights
- Factors Affecting All Competitors
- US Ultrasound Contrast Agent Market Drivers
- US Ultrasound Contrast Agent Market Limiters
- Ultrasound Contrast Agent Market, US (USD), 2019-2032
- Ultrasound Contrast Agent Market, US (USD), 2019-2032
- Ultrasound Contrast Agent Revenue Market Shares, US, 2022
- Ultrasound Contrast Agent Revenue Market Shares, US, 2022
- US Ultrasound Contrast Agent Market Competitive Insights
- Abbreviations
